Wikipedia -WSS

Wikipedia

author：leisure time 2025-10-02 19:21:02 - browse：8886

A photo of Robert Blum speaking at the STAT Summit West on May 16, 2024 — Cytokinetics CEO Robert Blum spoke last week at a talk during STAT’s Breakthrough Summit West in San Francisco. Sarah Gonzalez for STAT

Cytokinetics, a drugmaker that is expected to soon launch a promising new heart therapy called aficamten, said Wednesday that it had agreed to pay biotech firm Royalty Pharma a higher royalty on the medicine in return for up to $575 million, which will be used to fund the marketing of the drug and Cytokinetics’ ongoing research and development efforts.

Cytokinetics shares fell nearly 10% in after-hours trading after the announcement, which investors viewed as lowering the odds that the company will be purchased by a larger pharmaceutical company.

The firm also said that it would be raising $500 million through a stock sale.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： As AI regulations shape up, health tech startups beg for clarity

hotspot

WSS

Lung cancer screening guidelines updated for cigarette smokers

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

WATCH: Why do our ears pop?

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Hospitals are piloting generative AI tools as regulators play catch

Abridge raises $150m as clinical notes automation market heats up

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Activists slam private health insurers over coverage restrictions

Infant mortality in U.S. rose last year for first time in decades: CDC

Hepatitis C has a cure — but many Americans still lack access to it

Obamacare plans could cover weight loss drugs

Alkermes shareholders re

Brain injuries and the importance of a second opinion

23andMe had bad news about my health. I wish a person had delivered it

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Medical leaders decry Supreme Court decision on affirmative action

Readout LOUD podcast: ESMO highlights & Roivant's big deal

knowledge

Hospitals are piloting generative AI tools as regulators play catch

In 'major milestone,' FDA approves first cell therapy for solid tumors

As AI regulations shape up, health tech startups beg for clarity

A new drug could help frostbite victims avoid its ravages

Weight loss drugs aren’t covered by Obamacare. That may change

How neuroscience research could help beat back brain cancer

leisure time

hotspot

Wikipedia

hotspot